Synonyms: Anhydrous, Levofloxacin; Levaquin; Cravit; AC1L3YF8; SCHEMBL15397; BSPBio_002689; KBioGR_001605; KBioSS_002199; fluoro-methyl-(4-methylpiperazin-1-yl)-oxo-[?]carboxylic acid; MLS000759524; MLS001165709; MLS001423977; SPECTRUM1504260; Iquix; SPBio_001891; DTXSID0041060; KBio2_002199; KBio2_004767; KBio2_007335; KBio3_001909; BIL1009; EBD8264; GSDSWSVVBLHKDQ-JTQLQIEISA-N; ZX-AFC000651; Levofloxacine; HMS1922J07; HMS2051G04; HMS2090O10; HMS2093E18; HMS2232G06; Pharmakon1600-01504260; ZINC538273; BCP22048; EX-A1488; HY-B0330; Tavanic; Levofloxacin, >=98.0% (HPLC); BDBM50366826; BG0235; CCG-39093; DE-108; MMV687798; NSC758709; s1940; AKOS008901361; AKOS015895104; (-)-Ofloxacin; AC-7593; AN-8873; API0007780; CS-2218; DB01137; MCULE-2011834955; NC00094; NSC-758709; NCGC00178529-01; NCGC00178529-03; Ofloxacin S-(-)-form; (-)-(S)-9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyridol[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid hemihydrate; (-)-(S)-9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7Hpyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid hemihydrate; AJ-23383; AS-31796; LVX; SAM001246758; Levofloxacin, analytical reference material; SBI-0206768.P001; AB0072147; AB1009501; (S)-Ofloxacin; LS-133260; LS-171761; FT-0627808; L0193; ST24047487; C07660; D08120; AB00171657-12; AB00171657-13; AB00171657_14; Levofloxacino; AB00171657_15; 986L854; SR-05000001999; Levofloxacin, Antibiotic for Culture Media Use Only; SR-05000001999-1; BRD-K09471561-001-06-7; Z1766089137; UNII-A4P49JAZ9H component GSDSWSVVBLHKDQ-JTQLQIEISA-N; Levofloxacin solution, 1.0 mg/mL in acetonitrile, certified reference material; (-)-Ofloxacin; (-)-(S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazin-yl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid; Levofloxacinum; (2S)-7-fluoro-2-methyl-6-(4-methylpiperazin-1-yl)-10-oxo-4-oxa-1-azatricyclo[7.3.1.0;{5,13}]trideca-5(13),6,8,11-tetraene-11-carboxylic acid; (2S)-7-fluoro-2-methyl-6-(4-methylpiperazin-1-yl)-10-oxo-4-oxa-1-azatricyclo[7.3.1.0^{5,13}]trideca-5(13),6,8,11-tetraene-11-carboxylic acid; (S)-(-)-9-fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzooxazine-6-carboxylic acid; (S)-9-fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]-benzoxazine-6-carboxylic acid; 7H-Pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid, 2,3-dihydro-9-fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-, hemihydrate, (S)-; LVFX; RWJ 25213; L-Ofloxacin; Ophthalmic; (-)-(S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazin-yl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid; ofloxacin; d-Levofloxacin; R-Ofloxacin; Floxin; Elequine; Not Available; FLUOROQUINOLONE; Levofloxacin Anhydrous; Oftaquix (TN); Tavanic (TN); Quixin (TN); Levofloxacin Hemihydrate; Iquix (TN); Anhydrous, Levofloxacin; Ofloxacin, (S)-Isomer; Levofloxacin; Oftaquix; CHEMBL33; D02RSN; DR 3354; Levofloxacin, 98% - 25G 25g; C18-H20-F-N3-O4; CID149096; ACN-038325; CS-O-01741; A5511; B1959; L-Ofloxacin; D064704; (S)-9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-3,7-dihydro-2H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid; 8-Fluoro-3-methyl-9-(4-methyl-piperazin-1-yl)-6-oxo-2,3-dihydro-6H-1-oxa-3a-aza-phenalene-5-carboxylic acid; 82419-36-1; Floxacin; (S)-(-)-Ofloxacin; DR-3355; Levofloxacine [INN-French]; Levofloxacinum [INN-Latin]; Levofloxacino [INN-Spanish]; DR3355; HR 355; Levofloxacin Anhydrous; Levofloxacin [USAN:INN:JAN]; Levofloxacin hydrate; RWJ 25213-097; UNII-RIX4E89Y14; MP-376; RWJ-25213; CCRIS 4074; Levofloxacin (Levaquin); Levaquin (TN); LEVAQUIN IN DEXTROSE 5% IN PLASTIC CONTAINER; Ofloxacin, (S)-Isomer; RIX4E89Y14; (3S)-9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid; (S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid; CHEBI:63598; CPD000466387; (-)-(S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid; (S)-9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid; LFX; Q-201295; Aeroquin; Quixin; Leroxacin; Lesacin; Levokacin; Levoxacin; Mosardal; Nofaxin; Reskuin; Unibiotic; Venaxan; Volequin; LEVOFLOXACIN; Floxel; Levox; Loxof; 138199-71-0; Cravit Ophthalmic; C18H20FN3O4.H2O; ()-(S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1;()-(S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1; (3S)-(-)-9-Fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid; 7H-Pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid, 2,3-dihydro-9-fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-, (S)-; 7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid, 9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-, (3S)-; 100986-85-4; SMR000466387; (R)-isomer; Cravit (TN); Levofloxacin (INN); S-(-)-Ofloxacin; CCRIS 4073; C18H20FN3O4; Levofiexacin; Cravit hydrate; Iquix hydrate; Levaquin; Levaquin hydrate; Levo Floxacin; MFCD00865049; HSDB 8028; Cravit IV; Levofloxacin,(S); DR-3355: L-isomer of ofloxacin; (3s)-9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7h-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid; (R)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid; AK163316; Quixin; DRG-0129; levofloxacin-levaquin; HR-355; MP 376; Spectrum_001719; Spectrum2_001676; Spectrum3_000995; Spectrum4_001123; Spectrum5_001438; Levofloxacin tablet, suspension or intravenous;